ArticleSignal transduction and targeted therapy2020

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.

Chaoqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.